Industry and politicians disagree on new drug safety fee plan
European politicians and industry have disagreed on new plans to ask pharmaceutical firms to pay fees for drug safety assessments.
Archives for February 24, 2014
US FDA's 'super-office' to focus on all things quality, home and away
Development of a new quality "super office" was motivated by a desire to simplify oversight and is not a response to the recent spate of problems at overseas suppliers, says the US FDA.
Icon: FY13 bolstered by M&A strategy, bolt-on acqusitions to continue
Icon says it intends to continue its M&A strategy focusing on capabilities, geographies and technologies as it reports a robust 2013.
Private equity firm buys Medpace for $915m, citing growth opportunities
CRO consolidation has left market opportunities for providers who serve mid-size pharma, UK-based private equity firm Cinven says as it acquires Medpace.
Parexel launches regulatory service for approved drugs to fill outsourcing gap
Parexel says a service which manages regulatory activities for already approved drugs fills a gap in the market for pharmaceutical companies feeling the pressure to be efficient.